Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,783.85
-19.25 (-1.07%)
At close: Jul 17, 2026
Emcure Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Emcure Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹1,914. The average 1-year stock price forecast is 7.27% higher than the current stock price, while the lowest is ₹1,640 (-8.06%) and the highest is ₹2,100 (+17.72%).
Price Target: ₹1,914 (+7.27%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Emcure Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
104.40B
from 92.04B
Increased by 13.43%
Revenue Next Year
117.03B
from 104.40B
Increased by 12.10%
EPS This Year
60.83
from 52.29
Increased by 16.33%
EPS Next Year
74.70
from 60.83
Increased by 22.80%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.